0001127602-15-006167.txt : 20150218
0001127602-15-006167.hdr.sgml : 20150216
20150217115847
ACCESSION NUMBER: 0001127602-15-006167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150213
FILED AS OF DATE: 20150217
DATE AS OF CHANGE: 20150217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAREXEL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0000799729
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 042776269
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7814879900
MAIL ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VON RICKENBACH JOSEF H
CENTRAL INDEX KEY: 0001007706
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21244
FILM NUMBER: 15619692
MAIL ADDRESS:
STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION
CITY: WALTHAM
STATE: MA
ZIP: 02451-1163
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-02-13
0000799729
PAREXEL INTERNATIONAL CORP
PRXL
0001007706
VON RICKENBACH JOSEF H
PAREXEL INTERNATIONAL CORPORATION
195 WEST STREET
WALTHAM
MA
02451
1
1
Chairman & CEO
Common Stock
2015-02-13
4
M
0
100000
30.18
A
651806
D
Common Stock
2015-02-13
4
M
0
34650
21.97
A
686456
D
Common Stock
2015-02-13
4
M
0
37925
20.26
A
724381
D
Common Stock
2015-02-13
4
F
0
117098
63.09
D
607283
D
Common Stock
2015-02-13
4
S
0
61000
62.49
D
546283
D
Common Stock
2015-02-13
4
S
0
4100
63.11
D
542183
D
Stock Option (Right to Buy)
30.18
2015-02-13
4
M
0
100000
0
D
2016-09-11
Common Stock
100000
0
D
Stock Option (Right to Buy)
21.97
2015-02-13
4
M
0
34650
0
D
2018-09-15
Common Stock
34650
0
D
Stock Option (Right to Buy)
20.26
2015-02-13
4
M
0
37925
0
D
2019-09-21
Common Stock
37925
37925
D
Includes 240 shares of common stock acquired pursuant to the Issuer's 2000 Employee Stock Purchase Plan.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $62.00-$62.99. The price reported in this column reflects the weighted average sales price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price, upon request.
This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $63.00-$63.30. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
Currently exercisable
Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant.
/s/Douglas A. Batt, Attorney-In-Fact
2015-02-16